Last reviewed · How we verify
NCT04362579
Advanced Multi-Modal Wearable Sensing for the Prediction of Pre-Term Labor
trial testing wearable vital signs sensor in Pregnancy Preterm in 91 participants. Completed in 1 December 2021.
1 December 2021
Quick facts
| Lead sponsor | Northwestern University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 91 |
| Start date | 1 January 2021 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- wearable vital signs sensor
Conditions studied
- Pregnancy Preterm — all drugs for Pregnancy Preterm →
Sponsor
Northwestern University
Who can join
18 and older, female only, with Pregnancy Preterm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04362579
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of wearable vital signs sensor
Trials testing the same drug.
- NCT04362553 — Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring · completed
- NCT04343482 — Maternal Non-Stress Testing · completed
Other recruiting trials for Pregnancy Preterm
Currently open trials in the same condition.
- NCT06963528 — Gestational Diabetes Monitoring and Management · active not recruiting
- NCT04433364 — COPE - COVID-19 in Pregnancy and Early Childhood · active not recruiting
- NCT05651347 — Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction · Phase 3 · recruiting
Other Northwestern University trials
Trials by the same sponsor.
- NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
- NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
- NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
- NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
- NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04362579 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwestern University
- Last refreshed: 3 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04362579.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing